Literature DB >> 1176813

Degradation of insulin in serum by insulin-specific protease.

J I Starr, D D Juhn, A H Rubenstein.   

Abstract

The effect of insulin specific protease (ISP) in degrading plasma insulin over a wide concentration range was studied. In sera containing more than 50 muU per milliliter, more than 85 per cent of the insulin was destroyed. However, a smaller percentage of the hormone was degraded in sera containing less than 20 muU per milliliter and the results were highly variable. The residual insulin-like immunoreactivity in plasma after exposure to ISP thus represents both undegraded insulin as well as proinsulin. These findings explain the higher plasma proinsulin values obtained by the enzyme method when compared to gel filtration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1176813

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  Inhibition of insulin degradation by nonsuppressible insulin-like activity.

Authors:  G Burghen; W C Duckworth; A E Kitabchi; S S Solomon; P L Poffenbarger
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

2.  Specific and direct radioimmunoassay for human proinsulin in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

3.  Measurement of human proinsulin by an indirect two-site immunoradiometric assay.

Authors:  S J Rainbow; J S Woodhead; D K Yue; S D Luzio; C N Hales
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.